Evidence map›Paper›PMID 31325402›Full record

ArticleJournal of the European Academy of Dermatology and Venereology : JEADV2020

Reflectance confocal microscopy and dermoscopy aid in evaluating repigmentation within or adjacent to lentigo maligna melanoma surgical scars.

C Navarrete-Dechent, M Cordova, K Liopyris, A Rishpon, S Aleissa, A M Rossi, E Lee, C-C J Chen, K J Busam, A A Marghoob and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of the European Academy of Dermatology and Venereology : JEADV, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 1 institution in 3 countries.

C Navarrete-DechentDermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID https://orcid.org/0000-0003-4040-3640
M CordovaDermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
K LiopyrisDermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID https://orcid.org/0000-0001-9566-8238
A RishponDermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID https://orcid.org/0000-0003-0555-4822
S AleissaDermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
A M RossiDermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
E LeeDermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
C-C J ChenDermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
K J BusamDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
A A MarghoobDermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
K S NehalDermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Memorial Sloan Kettering Cancer Center · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

backgroundDetermining whether repigmentation within or adjacent to lentigo maligna or lentigo maligna melanoma (LM/LMM) scars represents recurrence of melanoma is challenging. The use of reflectance confocal microscopy (RCM) and dermoscopy may aid in differentiating true melanoma recurrence from other causes of repigmentation.

objectivesTo describe the characteristics of repigmentation within or adjacent to LM/LMM scars observable on RCM and dermoscopy.

methodsWe retrospectively analysed patients who presented with new pigmentation within or adjacent to scars from surgically treated LM/LMM between January 2014 and December 2018. Clinical and demographic characteristics and time to recurrence were recorded. RCM was used to evaluate areas of pigmentation before biopsy. If available, dermoscopic images were also evaluated.

resultsIn total, 30 confocal studies in 29 patients were included in the study cohort. Twenty-one patients had biopsy-confirmed recurrent LM/LMM; the remainder had pigmented actinic keratosis (n = 4) or hyperpigmentation/solar lentigo (n = 5). RCM had sensitivity of 95.24% (95% CI, 76.18-99.88%), specificity of 77.7% (95% CI, 39.99-97.19%), positive predictive value of 90.91% (95% CI, 74.58-97.15%) and negative predictive value of 87.5% (95% CI, 50.04-98.0%). The most common dermoscopic feature observed among patients with recurrent LM/LMM was focal homogeneous or structureless areas of light-brown pigmentation (92.8% vs. 37.5% in patients with other diagnoses; P = 0.009). LM-specific dermoscopic criteria were present in only 28.5% of patients with recurrent LM/LMM.

conclusionsReflectance confocal microscopy and dermoscopy are valuable tools for the comprehensive evaluation of repigmentation within or adjacent to LM scars.

Indexed as

DermoscopyMicroscopy, ConfocalAgedAged, 80 and overCicatrixDiagnosis, DifferentialFemaleHumansHutchinson's Melanotic FreckleHyperpigmentationMiddle AgedNeoplasm Recurrence, LocalRetrospective StudiesSensitivity and SpecificitySkin Neoplasms

Identifiers

PMID31325402
PMCPMC7592341
OpenAlexW2962871432

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.